InsiderDB

Lobbying disclosures · Lobbying report

ABBV: second_quarter 2026 lobbying report

International tax issues and pharmaceutical pricing and access issues, and patent issues. International tax issues and pharmaceutical pricing and access issues, and patent issues.

Follow ABBV
Became public
Jul 7, 2026, 1:58 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 9:38 AM EST

Why this is connected

Exact legal-name match: AbbVie Inc. (https://www.sec.gov/Archives/edgar/data/1551152/).

Reported lobbying amounts

Income: $80,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/d3f79ead-efa8-4585-9725-341ed6f72c3a/","filing_uuid":"d3f79ead-efa8-4585-9725-341ed6f72c3a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d3f79ead-efa8-4585-9725-341ed6f72c3a/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-07T13:58:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":210732,"url":"https://lda.gov/api/v1/clients/210732/","client_id":1008718,"name":"ABBVIE INC.","general_description":"Biopharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"International tax issues and pharmaceutical pricing and access issues, and patent issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63745,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"WEBSTER","suffix":null,"suffix_display":null},"covered_position":"Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons)","new":false},{"lobbyist":{"id":70188,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"GOODMAN","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff House Member Office (Kind), Legislative Staff House Member Office (Braley, Barrow)","new":false},{"lobbyist":{"id":34903,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"CRUMBLISS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73382,"prefix":null,"prefix_display":null,"first_name":"STACY","nickname":null,"middle_name":null,"last_name":"RICH","suffix":null,"suffix_display":null},"covered_position":"Leadership Staff Director, Senior Leadership Advisor and Floor Director, Leadership Advisor (Senate -Murray); Senate Cloakroom Asst, Dem Cloakroom (Reid, Daschle); Staff/Press Asst (Daschle)","new":false},{"lobbyist":{"id":69536,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"SANDELL","suffix":null,"suffix_display":null},"covered_position":"Tax Counsel, Legislative Assistant; Ways and Means Committee (Camp, Ryan, Brady)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"International tax issues and pharmaceutical pricing and access issues, and patent issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63745,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"WEBSTER","suffix":null,"suffix_display":null},"covered_position":"Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons)","new":false},{"lobbyist":{"id":34903,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"CRUMBLISS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73382,"prefix":null,"prefix_display":null,"first_name":"STACY","nickname":null,"middle_name":null,"last_name":"RICH","suffix":null,"suffix_display":null},"covered_position":"Leadership Staff Director, Senior Leadership Advisor and Floor Director, Leadership Advisor (Senate -Murray); Senate Cloakroom Asst, Dem Cloakroom (Reid, Daschle); Staff/Press Asst (Daschle)","new":false},{"lobbyist":{"id":69536,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"SANDELL","suffix":null,"suffix_display":null},"covered_position":"Tax Counsel, Legislative Assistant; Ways and Means Committee (Camp, Ryan, Brady)","new":false},{"lobbyist":{"id":70188,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"GOODMAN","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff House Member Office (Kind), Legislative Staff House Member Office (Braley, Barrow)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+0.37% ABBV

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.